Zeria Pharmaceutical Co (TSE:4559) Change In Receivables : 円0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co Change In Receivables?

Zeria Pharmaceutical Co's change in receivables for the quarter that ended in Dec. 2023 was 円0 Mil. It means Zeria Pharmaceutical Co's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Zeria Pharmaceutical Co's change in receivables for the fiscal year that ended in Mar. 2024 was 円-2,075 Mil. It means Zeria Pharmaceutical Co's Accounts Receivable increased by 円2,075 Mil from Mar. 2023 to Mar. 2024 .

Zeria Pharmaceutical Co's Accounts Receivable for the quarter that ended in Dec. 2023 was 円24,384 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zeria Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 104.75.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zeria Pharmaceutical Co's liquidation value for the three months ended in Dec. 2023 was 円-29,284 Mil.

Zeria Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Zeria Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co Change In Receivables Chart

Zeria Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

1,573.79

825.61

-2,029.75

-171.93

-2,075.17

Zeria Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Zeria Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Zeria Pharmaceutical Co (TSE:4559) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zeria Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	24384.166	/	21240.792	*	91
=	104.75

2. In Ben Graham's calculation of liquidation value, Zeria Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Zeria Pharmaceutical Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	19534.58	-	74330.057	+	0.75 * 24384.166	+	0.5 * 14446.424
=	-29,284

Zeria Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zeria Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zeria Pharmaceutical Co (TSE:4559) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351

Website

http://www.zeria.co.jp

Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co (TSE:4559) Headlines

No Headlines